Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Nehring · SciRah

Researcher profile · Semantic Scholar

L. Nehring

Share profile

L. Nehring — researcher profile on SciRah

h-index: 7
Works: 21
Citations: 1,143

Most-cited papers

Matrix metalloproteinases generate angiostatin: effects on neovascularization.
L. Cornelius, L. Nehring, Elizabeth O. Harding, M. Bolanowski +4 more
1998Journal of Immunology474 citations
Semantic Scholar
Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases.
A. M. Houghton, Jay L. Grisolano, Mary L. Baumann, D. Kobayashi +4 more
2006Cancer Research189 citations Open access
Semantic Scholar
Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration.
L. Cornelius, L. Nehring, J. Roby, W. Parks +1 more
1995Journal of Investigative Dermatology139 citations Open access
Semantic Scholar
Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones.
D. Busiek, V. Baragi, L. Nehring, W. C. Parks +1 more
1995Journal of Immunology117 citations
Semantic Scholar
Proteinase-activated Receptor-1 Regulation of Macrophage Elastase (MMP-12) Secretion by Serine Proteinases*
S. Raza, L. Nehring, S. Shapiro, L. Cornelius
2000Journal of Biological Chemistry97 citations Open access
Semantic Scholar
The Extracellular Matrix Protein MAGP-2 Interacts with Jagged1 and Induces Its Shedding from the Cell Surface*
L. Nehring, A. Miyamoto, Patrick W. Hein, G. Weinmaster +1 more
2005Journal of Biological Chemistry59 citations Open access
Semantic Scholar
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X. Ma, V. Suman, M. Goetz, D. Northfelt +30 more
2017Clinical Cancer Research57 citations Open access
Semantic Scholar
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial
Tim Kong, A. Mabry, M. Highkin, Anthony Z. Wang +30 more
2026Nature Communications5 citations Open access
Semantic Scholar
The angiogenic factor bFGF upregulates matrix metalloproteases in human dermal microvascular endothelial cells through transcriptional regulation and induces c-fos and c-jun nuclear proteins
L. Cornelius, L. Nehring, R. Pierce
19964 citations
Semantic Scholar
A phase I/II trial evaluating the safety and efficacy of eribulin in combination with copanlisib in patients with metastatic triple-negative breast cancer (TNBC).
N. Bagegni, L. Nehring, Jill Anderson, Brittney Haas +11 more
2022Journal of Clinical Oncology3 citations
Semantic Scholar
Abstract PO1-06-14: Preliminary results of a phase I dose escalation study of eribulin in combination with copanlisib in patients with metastatic triple negative breast cancer (TNBC)
N. Bagegni, Brittney Haas, L. Nehring, J. Luo +5 more
2024Cancer Research1 citations
Semantic Scholar
CTIM-24. PHASE II TRIAL OF RHIL-7-HYFC IN PATIENTS WITH HIGH-GRADE GLIOMA DEMONSTRATED ACCEPTABLE SAFETY PROFILE AND REDUCED LYMPHOPENIA
Yuping Derek Li, J. Luo, Cierra Grote, L. Nehring +11 more
2024Neuro-Oncology1 citations Open access
Semantic Scholar
Abstract P3-06-07: Phase Ib/II study to evaluate safety and tolerability of cabiralizumab in combination with nivolumab and neoadjuvant chemotherapy in patients with localized triple-negative breast cancer
A. Davis, L. Hernandez-Aya, Jingqin R Luo, M. Opyrchal +11 more
2023Cancer Research1 citations
Semantic Scholar
Abstract OT3-11-01: TK IMPACT: Treatment Monitoring of Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Metastatic Breast Cancer (MBC) Patients Receiving CDK 4/6 Inhibitors (CDK4/6i) with DiviTum® Thymidine Kinase 1 Activity
N. Bagegni, I. Grigsby, L. Nehring, Jingqin R Luo +13 more
2023Cancer Research1 citations
Semantic Scholar
Abstract PS12-03: Molecular characterization of the NeoPalAna Endocrine Resistant (ET-R) Cohort: implications for CDK4/6 inhibitor (CDK4/6i) and ET resistance mechanisms in primary estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC)
Tim Kong, A. Mabry, J. Luo, Anthony Z. Wang +23 more
2025Clinical Cancer Research0 citations
Semantic Scholar
CTIM-23. A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) AND EPACADOSTAT (IDO1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295
A. Butt, J. Luo, Yu Tao, Omar H. Butt +14 more
2024Neuro-Oncology0 citations Open access
Semantic Scholar
CTIM-30. NT-I7, A LONG-ACTING INTERLEUKIN-7, PROMOTES ACTIVATION, CYTOTOXIC FUNCTION, AND SELECTIVE CLONOTYPE EXPANSION OF CD8+ T CELLS IN PATIENTS WITH HIGH GRADE GLIOMAS
Kaiden Barozinsky, J. Foltz, Omar H. Butt, Alice Y. Zhou +17 more
2024Neuro-Oncology0 citations Open access
Semantic Scholar
A phase II trial of neoadjuvant MK2206, an AKT inhibitor, with anastrozole in clinical stage 2 or 3 PIK3CA mutant ER positive and HER2 negative breast cancer Estrogen receptor positive breast cancer, neoadjuvant endocrine therapy,
Cynthia X. Ma, V. Suman, M. Goetz, D. Northfelt +33 more
20170 citations
Semantic Scholar
2014 Summer National Meeting Louisville, KY CORPORATE GOVERNANCE (E) WORKING GROUP
Susan L. Donegan, J. Everett, Richard Ford, L. Nehring +6 more
20140 citations
Semantic Scholar
GROUP SOLVENCY ISSUES (E) WORKING GROUP
D. Saenz, J. Turchi, C. Neighbors, J. Weaver +12 more
20140 citations
Semantic Scholar
Biomarkers of response to neoadjuvant palbociclib plus Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/ anastrozole in endocrine-resistant estrogen receptor-positive/ HER2-negative breast cancer: A phase 2 trial HER2-negative breas
Tim Kong, Alex R. Mabry, M. Highkin, J. Hoog +30 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Cynthia X. Ma×9
Invite
Cynthia X. Ma — researcher profile on SciRah
F. Ademuyiwa×7
Invite
F. Ademuyiwa — researcher profile on SciRah
L. Cornelius×5
Invite
L. Cornelius — researcher profile on SciRah
J. Hoog×5
Invite
J. Hoog — researcher profile on SciRah

×5

Invite

Zhan-Fang Guo — researcher profile on SciRah

Invite

S. Sanati — researcher profile on SciRah

Invite

J. Luo — researcher profile on SciRah

Invite

R. Aft — researcher profile on SciRah

Invite

Yu Tao — researcher profile on SciRah

Invite

N. Bagegni — researcher profile on SciRah

Invite

H. Welgus — researcher profile on SciRah

Invite

O. Griffith — researcher profile on SciRah